On average, people taking injectable weight loss drugs lose 5%-23% of their body weight
8 Challenges and Considerations in Multi-Agonist Therapy Despite their advantages, GLP-1-based therapies face several challenges in adolescent populations: Gastrointestinal Side Effects: Nausea, vomiting, diarrhea, and constipation are common adverse events, especially during dose escalation
Do not forget to maintain a healthy lifestyle by engaging in regular physical activity and avoiding unhealthy habits that may interfere with fertility
The main components of weight gainer are
Early review can help adjust nutrition, activity, medication strategy, metabolic testing, or body-composition tracking before regain becomes harder to address